+

WO1994000019A1 - Produit cuit contenant des micro-organismes viables et son procede de preparation - Google Patents

Produit cuit contenant des micro-organismes viables et son procede de preparation Download PDF

Info

Publication number
WO1994000019A1
WO1994000019A1 PCT/DK1993/000207 DK9300207W WO9400019A1 WO 1994000019 A1 WO1994000019 A1 WO 1994000019A1 DK 9300207 W DK9300207 W DK 9300207W WO 9400019 A1 WO9400019 A1 WO 9400019A1
Authority
WO
WIPO (PCT)
Prior art keywords
microorganisms
suspension
baked product
product
species
Prior art date
Application number
PCT/DK1993/000207
Other languages
English (en)
Inventor
Bent Rasmussen
Alex Tolstoy
Original Assignee
FæLLESFORENINGEN FOR DANMARKS BRUGSFORENINGER (FDB)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FæLLESFORENINGEN FOR DANMARKS BRUGSFORENINGER (FDB) filed Critical FæLLESFORENINGEN FOR DANMARKS BRUGSFORENINGER (FDB)
Priority to AU43119/93A priority Critical patent/AU4311993A/en
Priority to JP6501964A priority patent/JPH08501209A/ja
Priority to EP93912692A priority patent/EP0649281A1/fr
Publication of WO1994000019A1 publication Critical patent/WO1994000019A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D15/00—Improving finished, partly finished or par-baked bakery products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms

Definitions

  • the present invention provides baked products containing dieteticaliy desirable viable microorganisms and a process for preparing such products.
  • the gastrointestinal tract of ani ⁇ mals including humans is colonized by a numerous and diverse population of indigenous microorganisms.
  • This naturally occurring intestinal microflora plays a significant role in maintaining the hosting macroorganism in a healthy condition due to several ecological effects of this microflora.
  • First of all an intact intestinal flora will constitute a barrier against colonization of pathogenic organisms passing the gastrointestinal tract and thereby provide a natural protec ⁇ tion against microbial diseases.
  • the indigenous microflora produce a number of enzymes and other metabolites which may supplement the digestion of nutrients which is caused by the natural digestive enzymes of the macroorganism.
  • the number of these nat ⁇ urally occurring intestinal microorganisms may be decreased or the beneficial balance between the species hereof may become less favourable to the host organism.
  • Examples of such conditions are stress conditions, treatments with anti ⁇ microbial medicaments or inappropriate diets.
  • These condi ⁇ tions may result in an increased susceptibility to acquiring diseases or in functional disturbances in the digestive tracts such as e.g. diarrhoea or constipation.
  • it may be advantageous to correct the disturbances of the natural microbial flora by administering to an individual suffering from such disturb ⁇ ances a large number of beneficial microorganisms which are capable of surviving or even colonizing the gastrointestinal tract.
  • Examples of microorganisms which are currently admin ⁇ istered with this purpose are lactic acid bacteria and yeast cultures.
  • beneficial microorganisms is not only considered advantageous for individuals having recognizable disturbances of their gastrointestinal flora. It is thus contemplated that even individuals without such recognizable disturbances may benefit from the administration as the above-defined function of their indigenous flora may be enhanced hereby.
  • Administration of dieteticaliy effective microbial cultures may be via the diet such as by consumption of fermented dairy products or other food products including meat products and fermented vegetable products, containing viable lactic acid bacteria.
  • the cultures may also conveniently be administered in the form of concentrates of the microorga ⁇ nisms, e.g. in the form of suitably formulated preparations including powders, granulates, tablets or capsules containing a high number of one or more species of the beneficial micro- organisms.
  • such concentrated dosage forms are relatively expensive and hence, their distribution is still limited.
  • bakery products are usually subjected to baking temperatures which will kill microorganisms except extremely thermotolerant species or thermotolerant forms of microor ⁇ ganisms.
  • the present invention provides for the first time baked products which contain a dieteticaliy desirable number of beneficial microorganisms as they have been defined above.
  • the present invention relates to a method of preparing a bakery product containing viable micro ⁇ organisms, comprising the steps of (1) preparing a baked product and cooling it to a temperature in the range of 0 to 70°C, (2) preparing a suspension of microorganisms, contain ⁇ ing 10 7 to 10 12 viable organisms per mL, (3) injecting into the baked product a volume of the suspension of micro ⁇ organisms which is in the range of 2 to 20 mL per kg of product, to obtain the baked product having a content of viable microorganisms which is in the range of 10 3 to
  • 2 x 10 10 per g including contents which are in the range of 2 x 10 s to 2 x 10 10 per g.
  • the present invention pertains to a baked product having a content of viable microorganisms which is in the range of 10 3 to 2 x 10 10 per g.
  • baker's yeast is added during the preparation of the dough for many types of wheat flour based bread types including rolls and buns.
  • baker's yeast is added as a leavening agent and the leavening is a result of the production of gas from the metabolically active yeast cells.
  • viable bacterial cultures such as cultures of lactic acid bacteria are also added to the dough.
  • the purpose hereof is to confer to the bread a desired flavour of organic acids and other aromatic compounds.
  • bread products in which wheat flour is par ⁇ tially or completely replaced by rye flour are prepared from doughs comprising as a substantial ingredient a so-called "leaven” which is a culture of one or several species of lactic acid bacteria grown in an aqueous suspension of flour.
  • the lactic acid bacterial culture in such leavens may ori ⁇ ginate from the naturally occurring flora of lactic acid bacteria of the flour, or suitable commercial lactic acid bacterial starter cultures may be added.
  • Suitable lactic acid bacterial species for use in doughs include homofermentative species which predominantly produce lactic acid when sugars are fermented by them, and heterofermentative species which when fermenting sugars, in addition to lactic acid produce other acids including acetic acid and possibly propionic acid.
  • the present invention pro ⁇ vides a method of preparing a bakery product containing a high number of dieteticaliy desirable viable microorganisms which are introduced into the baked product by injecting into the baked product a suspension of the microorganisms.
  • thermotolerance i.e. the highest temperature at which sub ⁇ stantially none of the cells of a suspension of microorga- nisms as used herein are injured to an extent where they are no longer capable of growing under suitable growth condi ⁇ tions, may vary considerably.
  • a non-injuring temperature as defined above is in the range of 0 to 70°C. Accordingly, the baked product is cooled to a temperature within this range, the required cooling depending on the microorganism(s) used. Typically, the product is cooled to a temperature in the range of 20 to 65°C such as in the range of 50 to 60°C. In this context, it is important to note that a temperature gradient will occur during the cooling of a baked product. Depending on the desired site of injecting the microbial suspension the cool ⁇ ing is continued until a suitable temperature as defined above has been reached at that particular site.
  • a suitable micro- organism is one which confers to the baked product a desired dieteticaliy beneficial effect as it has been explained above and which microorganism is capable of maintaining its viabil ⁇ ity after injection into the product to a degree which results in the presence of a dieteticaliy effective amount of viable organisms herein at the time of consumption of the baked product.
  • a useful microorganism may be selected from a fungal species, a yeast species and a bacterial spe ⁇ cies.
  • microorganisms which when present in a baked product is capable of resisting the acidic conditions in the anterior parts of the gastrointestinal tract, in particular in the stomach and the anterior parts of the small intestines. Accordingly, particularly interesting microorganisms are microorganisms which inherently are tole ⁇ rant to acidic conditions. However, it is also possible to use less acid tolerant organisms provided they are provided in a form where they are protected against gastrointestinal acidic conditions.
  • the microorganism(s) may be coated or encapsulated by a suitable compound or suitable compounds which are insoluble under acidic conditions such as in the stomach or the anterior parts of the small intestines but which is/are dissolved when present in an environment with a pH in the range of e.g. 5 to 10. Any suitable coating or encapsulation method known in the art may be used.
  • the suspension of micro ⁇ organisms being injected may comprise organisms belonging to the same species or it may comprise microorganisms which are a mixture of species of microorganisms.
  • the microorganisms are orga ⁇ nisms belonging to one or more species of lactic acid bacteria.
  • This group of microorganisms having as a common characteristic the ability of producing lactic acid bacteria under microaerophilic or anaerobic conditions, comprise several genera including gram-positive organisms such as Lactobacillus, Lactococcus, Streptococcus, Leuconostoc and Pediococcus and Bifi oJbacterium.
  • the genus Lactobacillus include as typical examples the following species Lactobacillus acidophilus, Lactobacillus plantarum, Lacto- bacillus casei , Lactobacillus delbr ⁇ ckii , and Lactobacillus hilgardii .
  • a typical Bifidobacterium species is Bifidobacte ⁇ rium bifidum.
  • Streptococcus spp. Streptococcus thermo- philus and Streptococcus faecium may be used in accordance with the present invention.
  • Propionibacterium spp which are gram-positive anaerobic bacteria capable of fermenting lac- tate to propionate, including Propio-niJbacterium shermanii may be used, optionally in combination with one or more lactic acid bacterial species such as e.g. Lactobacillus acidophi ⁇ lus, Bifidobacterium bifidum or Streptococcus faecium.
  • lactic acid bacterial species are commonly used as starter cultures in the manufacturing of fermented food products, such as dairy products, meat products, vegetable products and as mentioned above, in the manufacturing of bread products.
  • lactic acid bacterial starter cultures comprise a mixture of species.
  • One typical , example hereof is the use of a mixture of Lactobacillus acidophilus and Bi.fidoJbacteriu-m bifidum in certain fermented milk products.
  • Lactobacillus acidophi ⁇ lus is considered to be particularly adapted to remain viable or even colonize in the anterior parts of the gastrointestinal tract whereas Bifidobacterium bifidum which is a strictly anaerobic organism assumingly will colonize the posterior parts of the intestines where the E h is low.
  • a dieteticaliy beneficial effect may be obtained throughout the major part of the gastrointestinal tract by providing in a food product including the baked product according to the present invention, a mixture of lactic acid bacterial species each of which is particularly adapted to colonize in different parts of the gastrointestinal tract.
  • a useful suspension of microorganisms comprises a mixture of a microaerophilic lactic acid bacterium such as a Lactobacillus species and a strictly anaerobic lactic acid bacterial species including a Bifidobacterium species.
  • a microaerophilic lactic acid bacterium such as a Lactobacillus species
  • a strictly anaerobic lactic acid bacterial species including a Bifidobacterium species.
  • useful microorganisms may in the present context include yeast organisms. Typical examples hereof are Saccharomyces cerevisiae e.g. in the form of baker's yeast, and Klyveromyces lactis .
  • the culture of microorganisms to be injected into the bakery products may comprise a mixture of bacterial and yeast organisms.
  • the microorganisms may be wild-type strains as isolated from their natural environment. It may, however, be advantageous to use microbial strains which have been improved be selection, by mutation or by genetic recombination.
  • the injected suspension of microorganisms is biologically pure, i.e. it should only contain the desired microorganisms and no or only few foreign microorganisms as contaminating orga- nisms.
  • contamination with undesired fungi are particularly serious as these organisms may be capable of multiplying under the conditions prevailing in bakery pro ⁇ ducts including the low a w .
  • the term "suspension of microorganisms" as used herein denotes a substantially pure suspension of the desired microorganisms.
  • the suspension of microorganisms being injected suitably contains 10 7 to 10 12 viable organisms per mL. In certain preferred embodiments, the content of microorganisms is in the range of 10 9 to 10 11 per mL.
  • the suspension of microorganisms is prepared from a concentrate of organisms containing 10 8 to 10 13 organisms per g. Such concentrates may be in the form of a slurry or paste of freshly grown micro ⁇ bial cells. However, in industrial production it may be more convenient to prepare the suspension from a frozen or freeze- dried concentrate of the microorganism(s) optionally contain ⁇ ing one or more cryoprotective substances.
  • the suspension of microorganisms may e.g. be prepared from a concentrate of organisms as defined above, by suspending 1 part of the concentrate of microorganisms in 5 to 20 parts of an aqueous medium comprising at least one microbial nutrient and at least one salt.
  • an aqueous medium may be one selected from distilled water, deionized water or tap water. It is well-known that in a concentrate of microorganisms as in the one presently defined, a certain proportion of the organisms may be in state of "stress" or sublethal injury, where maintenance of their viability is dependent on the presence in their environment of certain nutrients.
  • aqueous suspending medium may be any nutrient normally used in culturing media for particular microorganisms or the suspend- ing medium may be a commercial liquid culture medium such as e.g. the conventionally used tryptic soy broth medium, con ⁇ taining the required nutrients.
  • suitable nutrients may be selected from yeast extract which i.a. contain a variety of vitamins, peptides and amino acids; a carbon source which e.g.
  • the suspension medium may suitably contain a salt or a mixture of salts.
  • the salt(s) may be selected from an alkali metal salt such as NaCl or a phosphate and an alkaline earth metal salts including phosphates, chlorides or carbonates.
  • the suspension medium is preferably a sterile medium which may be provided by using only sterile ingredients or by subjecting the prepared medium to a treatment whereby con- taminating microorganisms are killed or removed.
  • treat ⁇ ments include heating at a temperature and for a period of time which results in a sterile or substantially sterile medium, and a filtering under conditions where microorganisms are separated from the medium.
  • the suspension may be left to stand at a tempe ⁇ rature in the range of 0 to 40°C such as at ambient tempe ⁇ rature for up till 6 hours such as about 15 to 120 minutes.
  • the volume of the suspension of microorganisms typically being injected into the baked product is in the range of 1 to. 50 mL, preferably in the range of 2 to 20 mL, per kg of product. The appropriate volume depends on the type of bakery product. It is essential that the volume injected does not exceed the volume which can be absorbed by the product with ⁇ out conferring to the product undesirable wet and "sticky" spots which can be recognized by the consumer.
  • the above volume ranges may be suitable for pieces of bakery products which have a weight being in the range of 0.2 to 2 kg.
  • the bakery products to be injected are in smaller pieces, such as buns or rolls having a weight e.g. in the range of 0.02 to 0.2 kg the volumes may conveniently be in the range of 0.1 to 2 mL, such as 0.25 to l mL.
  • any bakery product having a crumb structure and consistency allowing the injection and absorption of the suspension of microorganism(s) may be subjected to the injection of such a suspension.
  • interesting bakery products include ryebread products, yeast-leavened bakery products and chemically leavened bakery products.
  • Yeast-leavened bakery products include wheat flour based bread products in the form of wheat flour-containing loaves, buns or rolls, and pastry products.
  • chemically leavened bakery products typical examples are cakes such as sponge cakes, pound cakes, scones and muffins.
  • the bakery products containing the viable microorganisms may be packaged for display in retail shops e.g. in air-tight polymer foil materials, optionally as evacuated packages. When the bakery product is one which is consumed in slices, the packaged product may be provided as slices.
  • the suspension of microorganisms is injected into the baked and cooled product through a multiplicity of needles having a length which is in the range of 5 to 100 cm and a diameter which is typically in the range of 0.5 to 3.0 mm such as about 2 mm, said needles being connected to one or more reservoirs containing the microbial suspension(s) .
  • a suitable length of the needles depend on the dimension of the product to be injected. In useful embodiments the needle length is 10 to 40 cm.
  • the injection of the suspension of microorganisms into the bakery product may take place during introduction of the needles or it occur during the retrograde movements of the needles. Most conveniently, however, the injection may take place during introduction as this allows the inner space of the needles to become refilled with the suspension during the retrograde movement.
  • the direction of the needles in relation to the bakery product to be injected may be varied e.g. depending on the outer dimensions of the product. As an example, a loaf of ryebread or a loaf of wheat flour bread may conveniently be injected longitudinally.
  • the injection of the microbial suspension may be carried out manually such as by a syringe or a multiplicity of syringes provided with a needle
  • the injection is pre- ferably carried out by means of an apparatus comprising (1) means for introducing the suspension into the baked product, (2) means for containing the suspension to be injected, (3) means for connecting the reservoir with said means for introducing the suspension, (4) means for pneumati- cally transporting the suspension from the containing means and to the introducing means, and for pneumatically introduc ⁇ ing the means for introducing the suspension into the baked • product, (5) means for adjusting the volume to be injected, and (6) means for maintaining the baked product to be injected in a position which allows the introduction of the suspension thereinto.
  • the means for introducing the suspension of microorganisms into the baked product comprise a multiplicity of needles having the above-defined dimensions.
  • a suitable number of needles depends on the dimension of the baked product to be injected, a suitable number of needles typical ⁇ ly being in the range of 2 to 20 such as e.g. in the range of 3 to 10.
  • the needles are placed equidistantly.
  • Suitable means for containing the suspension(s) of micro ⁇ organisms include metal, glass and plastic containers such as tanks, bottles or jars.
  • the means may comprise a multiplicity of containers connected to different needles thus allowing simultaneous injection of separate microbial cultures.
  • the means for pneu ⁇ matically transporting the suspension of microorganism(s) is activated during the introduction into the baked product of the means for introducing the suspension.
  • the suspension of microorganisms may advantageously be injected into the baked product during introduction of the needles.
  • the apparatus may be constructed so that the means for introducing the suspen ⁇ sion is filled or refilled with suspension during retrograde movements of the means.
  • the means for adjusting the total volume to be injected into one piece of bakery product may be constructed so as to allow adjustment of a volume which is in the range of 2 to 20 mL, preferably in the range of 3 to 15 mL such as in the range of 5 to 12 mL, e.g. a volume of about 10 mL.
  • a volume which is in the range of 2 to 20 mL, preferably in the range of 3 to 15 mL such as in the range of 5 to 12 mL, e.g. a volume of about 10 mL.
  • These volume ranges may be suitable for pieces of bakery products which have a weight being in the range of 0.2 to 2 kg.
  • the bakery products to be injected are in smaller pieces, such as buns or rolls having a weight e.g. in the range of 0.02 to 0.2 kg the volumes may conveniently be in the range of 0.1 to 2 mL, such as 0.25 to 1 mL.
  • the present invention provides in a further aspect a baked product prepared by the method as described herein which product has a content of viable dieteticaliy beneficial microorganisms as defined above, being in the range of 10 3 to 2 x 10 10 per g.
  • the content of microorganisms may suitably be in the range of 2 x 10 5 to 2 x 10 10 per g including contents in the range of 2 x 10 4 to 2 x 10 9 per g.
  • the desired content of viable microorganisms depends on the selected type(s) of microorganisms but it should preferably be at a level where a dieteticaliy effective amount of micro- organisms is provided in a typical serving of the particular bakery product. As one example, about 100 g of bread may typically be served for a meal. Assuming that a dieteticaliy beneficial amount of injected viable microorganisms per meal is about 1x10 s , the bread served should contain at least 10 6 viable microorganisms per g. Accordingly, the injected amount of microorganisms must be adjusted to result in such a desired minimum amount of viable microorganisms at any point of time between manufacturing and consumption.
  • the initial amount of viable microorganisms i.e. the amount hereof present in the baked product immediately fol ⁇ lowing injection must be selected at a higher level than the desired beneficial amount at the time of consumption so as to compensate for a possible reduction of viability during . storage.
  • the desired initial amount of viable microorganisms may be 5 to 100 times higher than the amount required to provide the dieteticaliy effective amount at the latest possible time of consumption.
  • a loaf of ryebread may therefore have an initial content of viable microorganisms which in the range of 5 x 10 8 to 10 9 per g.
  • the number of viable micro- organisms in the subject baked product is defined as the number hereof capable of growing under optimal conditions of growth.
  • the appropriate method of enumeration will depend on the particular type of microorganism(s) .
  • such methods may be conventional plate count methods using a growth medium suitable for the microorganisms used and incu ⁇ bating the medium inoculated with suitably diluted samples of the product under suitable atmospheric and temperature condi ⁇ tions and counting the number of colony forming units.
  • a "mother leaven" is prepared by inoculating 10 g of a commercial culture of Lactobacillus acidophilus sus ⁇ pended in 200 mL of demineralized water into a mixture of 2 kg of coarse rye flour and 2 L of water and incubating the resulting mixture at 38°C for about 8 hours followed by the addition to the mixture of additional rye flour and water and continued incubation at 38°C. This is repeated on the 2nd day and on the 3rd day after which the leaven is ready for use in bread manufacturing.
  • a dough was prepared according to the following recipe:
  • the ingredients except the soybean shells were mixed into a dough by kneading in a kneading apparatus for about 15 minu ⁇ tes and left to stand for about 15 minutes at a temperature of about 28 to 30°C.
  • the dough was portioned into 1100 g units being formed into loaf shape and covered with soybean shells and transferred to baking tins.
  • the loaves were next left to rise for about 50 minutes before being transferred to an oven having an initial temperature of 270°C and into which steam was lead during the baking process.
  • the baking time was about 75 minutes during which the temperature was gradually lowered to about 170°C.
  • the loaves were taken to a cooling tower in which air at a temperature of 5 to 7°C was circu ⁇ lated at a rate of 10.000 to 16.000 3 per hour. After cool- ing for about 45 minutes, the temperature in the bread crumb was about 66°C.
  • a suspension of microorganisms was prepared by suspending 1 g of a frozen culture of Lactobacillus acidophilus (Nu-trishTM, Chr. Hansen's Laboratorium Danmark A/S, H ⁇ rsholm, Denmark) containing about SxlO 11 viable organisms, 1 g of a frozen culture of Bifidobacterium bifidum (Nu-trishTM, Chr. Hansen's Laboratorium Danmark A/S, H ⁇ rsholm, Denmark) containing about 8.3X10 11 viable organisms in 10 g of suspension medium com ⁇ prising l wt% of sterile yeast extract, 0.9 wt% of sterile NaCl and 98.1 wt% of sterile distilled water.
  • the resulting suspension was left to stand for up till 6 hours at a temperature of about 37°C prior to injecting about 10 mL per kg into the baked and cooled loaves by means of a multiplicity of needles having a length of about 40 cm and diameter of about 3 mm.
  • the injected loaves were assessed with regard to crumb struc ⁇ ture, sensoric characteristics and crumb consistency.
  • the crumb structure showed an even satisfactory pore structure.
  • the bread had a rich smell of ryebread and a strong and rich taste of rye and linseed.
  • the salt and leaven contributed to the overall desired taste but these ingredients did not dominate the taste.
  • the consistency was assessed to be soft and suitably "wet” and the bread did not stick to the knife when cut. This desired consistency was kept satisfactorily during the 10 days period. The bread also had a desirable "resistance" on chewing.
  • Yeast-leavened retzel bakery product (“krin le") containing a mixture of Lactobacillus acidophilus, Bifidobacterium bifi- dum. Streptococcus faecium and Propionibacterium shermanii
  • the retzel product was made from a dough containing the following ingredients: wheat flour, vegetable and animal fat, skimmed milk, eggs, baker's yeast, sugar, salt and wheat starch.
  • the following food additives were added: modified starch, emulsifying agents (E 322, E 471, E 475, E 472e) , ascorbic acid, sodium carbonate, citric acid and flavouring agent.
  • the product contained a filling comprising: animal and ve ⁇ getable fat, sugar, muscovado, raisins, apricot kernels, soybean flour, acidified skimmed milk, starch, water, salt, egg white and whey powder.
  • the suspension medium for the bacterial cultures was Tryptone Soy Broth (TSB) (Oxoid CM129) and each of the bacterial suspensions contained 1 g of bacterial cultures in 10 mL of the suspension medium.
  • the Lactobacillus acidophilus culture used was the commercial frozen DVS (direct vat set) culture L. acidophilus La-5 (Chr. Hansen's Laboratorium Danmark A/S, H ⁇ rsholm, Denmark) which contains at least 6 x 10 10 colony forming units (CFUs) per g.
  • the Bifidobacterium bifidum culture was the frozen DVS culture Bifidobacterium Bb-12
  • the Streptococcus fae ⁇ cium culture which was used for preparing a suspension was the freeze-dried DRI-VAC culture Streptococcus faecium CH-1 (Chr. Hansen's Laboratorium Danmark A/S, H ⁇ rsholm, Denmark) containing 5 x 10 8 CFUs per g and the Propionibacterium shermanii culture used was the frozen DVS Propionic Acid Culture PS-1 (Chr. Hansen's Laboratorium Danmark A/S, H ⁇ rs ⁇ holm, Denmark) containing 3 x 10 9 per g.
  • the suspensions were left to stand for resuscitation at 37°C for 1-2 hours and then injected into the retzel product at amounts of 0.25 mL of each suspension by means of a syringe and the injected product was kept at room temperature until determi- nation of viable bacterial counts.
  • the contents of viable bacteria in a slice of about 1.5 cm thickness cut around the site of injection were determined according to the following methods: About 10 g of the above slice of product was homogenized in saline in a Stomacher for about 4 minutes and appropriate tenfold serial dilution were made. The viable counts of Lactobacillus acidophilus and of Bifidobacterium bifidum were done essentially according to the method defined in Example 1.
  • the viable count of Streptococcus faecium was done by plating onto blood agar (Blood agar base, Oxoid CM55 supple ⁇ mented with 5% calf blood) followed by aerobic incubation for 24 hours at 37°C.
  • the viable count of PrqpioniJbacteriut ⁇ shermanii cells was done by plating onto the above-defined blood agar and incubating anaerobically at 37°C for 48 hours.
  • the numbers of viable bacteria per g of the retzel product were as follows:
  • a sponge cake (“sandkage") containing a mixture of Lactobacillus acidophilus.
  • the sponge cake having a total weight of 350 g contained the following ingredients: margarine, water, sugar, wheat flour, starch, egg powder and milk powder.
  • the following food addi- tives were added to the batter: leavening agents (diphosphate salt, sodium hydrogen carbonate) , emulsifying agents (E 471, E 322, E 475) and aroma.
  • Example 2 0.25 mL volumes of the suspensions as defined in Example 2 were injected as also defined in Example 2, and after about 24 hours the bacterial counts (CFUs per g) were determined according to methods defined in Example 2 with the following results:
  • the bread was prepared from a dough containing the following ingredients: Wheat flour, water, baker's yeast, animal and vegetable fat, caseinate, salt, sugar and glucose; and the following food additives: emulsifying agents (E 482, E 475, E 471, E 322) and ascorbic acid.
  • emulsifying agents E 482, E 475, E 471, E 322
  • ascorbic acid 0.25 mL of the bacterial suspensions as defined in Example 2 were injected into a loaf of the bread having a weight of 300 g and the viable counts deter ⁇ mined after about 24 hours according to the methods as also defined in Example 2. The results of these counts are shown below:
  • the bread was prepared from a dough consisting of wheat flour, water, coarsely comminuted rye grains, whole-meal wheat flour, baker's yeast, linseed, sesame seed, salt, sugar; and the following food additive ingredients: emulsify ⁇ ing agent (E 472e) and ascorbic acid.
  • the dough was formed into loaves each having a weight of 520 g.
  • Example 2 After baking and cooling to a temperature below 70°C, 0.25 mL of the bacterial suspensions as defined in Example 2 were injected into a loaf of the bread and the viable counts determined after about 24 hours according to the methods as also defined in Example 2. The results of these counts are shown below:
  • the rolls were prepared from a dough consisting of wheat flour, water, baker's yeast, salt, sugar and eggs and a food additive ingredient mixture, Compound 80 (Faellesforeningen for Danmarks Brugsforeninger, Albertslund, Denmark) .
  • the dough was formed into rolls each weighing about 30 g and baked at 250 to 240°C for about 12 minutes. After baking and cooling to a temperature below 70°C, 0.25 mL of the bacterial suspensions as defined in Example 2 were injected into each roll and the viable counts of the injected bacteria were determined after about 24 hours according to the methods as also defined in Example 2 except that a whole roll of about 30 g was used the sample and homogenized by means of the Stomacher. The results of these counts are shown below:
  • Lactobacillus acidophilus ii) Lactobacillus acidophilus (ii) Bifidobacterium bifidum
  • This bread was prepared from a dough consisting of wheat flour, water, whole-meal wheat flour, wheat grains, whole ⁇ meal rye flour, baker's yeast, animal and vegetable fat, sugar, salt and starch; and the following food additives: emulsifying agents (E 471, E 472, E 322), phosphate (E 341) and ascorbic acid.
  • the dough was formed into loaves of a weight of 450 g.
  • Example 2 After baking and cooling the loaves to a temperature below 70°C, 0.25 mL of the bacterial suspensions as defined in Example 2 were injected into the bread and the viable counts of the injected bacteria were determined after about 24 hours and again after about 72 hours according to the methods as also defined in Example 2. The results of these counts are shown below: 24 hours 72 hours
  • This bread was prepared from a dough containing the following ingredients: leaven (water, whole-meal flour of rye, leaven culture) , water, whole-meal flour of rye, whole rye grains, dried crumbs of rye bread, salt, dried leaven (wheat flour, wheat bran, water, leaven culture) , wheat starch, yeast, malt extract, syrup.
  • leaven water, whole-meal flour of rye, leaven culture
  • water, whole-meal flour of rye whole rye grains
  • dried crumbs of rye bread salt
  • dried leaven wheat flour, wheat bran, water, leaven culture
  • wheat starch a dough starch
  • yeast malt extract
  • a suspension of baker's yeast Saccharomyces cerevisiae was prepared in the following manner: 1 g of the baker's yeast (MalteserkorsgasrTM, De Danske Spritfabrikker) was suspended in 10 mL of TSB and the suspension was kept for 60 minutes at 37°C and a sample was collected for determination of the viable yeast cell count (CFU per g) which was found to be about 1.8 x 10 9 CFU of yeast per mL. A loaf of the bread was injected essentially as described in Example 2 but using 1 mL of yeast suspension and kept at room temperature for about 24 hours.
  • the viable count of yeast in the slice of ryebread as exami- ned was 1.4 x 10 8 per g.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des produits de boulangerie diététiquement améliorés présentant une teneur en micro-organismes viables de l'ordre de 103 à 2 x 1010 par gramme, ainsi que leur procédé de préparation. Ces produits de boulangerie comprennent le pain de seigle, des pains ou des gâteaux contenant de la farine de blé, ainsi que des muffins et des scones.
PCT/DK1993/000207 1992-06-24 1993-06-23 Produit cuit contenant des micro-organismes viables et son procede de preparation WO1994000019A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU43119/93A AU4311993A (en) 1992-06-24 1993-06-23 Baked product containing viable microorganisms and process for preparing same
JP6501964A JPH08501209A (ja) 1992-06-24 1993-06-23 生存微生物を含有するベークト製品およびその製造方法
EP93912692A EP0649281A1 (fr) 1992-06-24 1993-06-23 Produit cuit contenant des micro-organismes viables et son procede de preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK0832/92 1992-06-24
DK92832A DK83292D0 (da) 1992-06-24 1992-06-24 Broedprodukt

Publications (1)

Publication Number Publication Date
WO1994000019A1 true WO1994000019A1 (fr) 1994-01-06

Family

ID=8098058

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK1993/000207 WO1994000019A1 (fr) 1992-06-24 1993-06-23 Produit cuit contenant des micro-organismes viables et son procede de preparation

Country Status (6)

Country Link
EP (1) EP0649281A1 (fr)
JP (1) JPH08501209A (fr)
AU (1) AU4311993A (fr)
CA (1) CA2138764A1 (fr)
DK (1) DK83292D0 (fr)
WO (1) WO1994000019A1 (fr)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5816190A (en) * 1995-02-24 1998-10-06 Van Der Lely; Cornelis Apparatus for milking animals
WO2001095741A1 (fr) * 2000-06-13 2001-12-20 Unilever N.V. Produit alimentaire contenant du lactobacille non-viable
EP1510135A1 (fr) * 2003-08-26 2005-03-02 Chr. Hansen A/S Aliment pour animaux de fermes comprenant enterococci probiotiques
WO2006041324A1 (fr) 2004-10-15 2006-04-20 Stanislaw Kalamarz Pate pour pain de seigle longue conservation et procedes de fabrication et de rafraichissement de ce pain
WO2007058614A1 (fr) * 2005-11-17 2007-05-24 Celac Sweden Ab Pain probiotique et son procede de fabrication
WO2007108764A2 (fr) 2006-03-17 2007-09-27 Probac Ab Souches de lactobacillus thermostables
WO2009069122A1 (fr) * 2007-11-26 2009-06-04 Zimand, Henri Procédé pour préparer un aliment probiotique pouvant être cuit
WO2011004375A1 (fr) 2009-07-09 2011-01-13 Rubin, Israel Compositions probiotiques résistant à la chaleur et aliments sains les comprenant
US8673377B2 (en) 2008-01-28 2014-03-18 Lallemand, Inc. Method for extending mold-free shelf life and improving flavor characteristics of baked goods
US9622502B2 (en) 2008-10-16 2017-04-18 Ganeden Biotech, Inc. Probiotic Bacillus pasta compositions
US10383342B2 (en) 2007-08-29 2019-08-20 Ganeden Biotech, Inc. Baked goods
US10543175B1 (en) 2013-05-17 2020-01-28 Degama Berrier Ltd. Film composition and methods for producing the same
US11039637B2 (en) 2010-12-06 2021-06-22 Degama Berrier Ltd. Composition and method for improving stability and extending shelf life of probiotic bacteria and food products thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2041056A (en) * 1933-10-28 1936-05-19 Walter L Fleisher Method for treating hygroscopic materials at subatmospheric pressures
FR1481243A (fr) * 1966-04-07 1967-05-19 P I Soc Armoricaine De Patisse Procédé d'aromatisation de pâtisserie et dispositif pour la mise en oeuvre de ce procédé
DE2511847A1 (de) * 1975-03-18 1976-09-23 Franken Zuckerfab Verfahren zum frischhalten von saccharosehaltigen dauerbackwaren
DE2832782B1 (de) * 1978-07-26 1979-08-23 Geerd 5372 Schleiden Kleinert Verfahren zur Herstellung Arzneimitteldrogen enthaltender Brot- und Backwarenzubereitungen
EP0154549A2 (fr) * 1984-03-09 1985-09-11 Kabushiki Kaisya Advance Agent anticarieux ou antipériodontique
US4806368A (en) * 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
EP0512857A2 (fr) * 1991-05-10 1992-11-11 Terutake Yabiki Composition qui contient un résidu de culture bactérien et des cellules bactériennes decapsulées et son utilisation

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2041056A (en) * 1933-10-28 1936-05-19 Walter L Fleisher Method for treating hygroscopic materials at subatmospheric pressures
FR1481243A (fr) * 1966-04-07 1967-05-19 P I Soc Armoricaine De Patisse Procédé d'aromatisation de pâtisserie et dispositif pour la mise en oeuvre de ce procédé
DE2511847A1 (de) * 1975-03-18 1976-09-23 Franken Zuckerfab Verfahren zum frischhalten von saccharosehaltigen dauerbackwaren
DE2832782B1 (de) * 1978-07-26 1979-08-23 Geerd 5372 Schleiden Kleinert Verfahren zur Herstellung Arzneimitteldrogen enthaltender Brot- und Backwarenzubereitungen
EP0154549A2 (fr) * 1984-03-09 1985-09-11 Kabushiki Kaisya Advance Agent anticarieux ou antipériodontique
US4806368A (en) * 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
EP0512857A2 (fr) * 1991-05-10 1992-11-11 Terutake Yabiki Composition qui contient un résidu de culture bactérien et des cellules bactériennes decapsulées et son utilisation

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5816190A (en) * 1995-02-24 1998-10-06 Van Der Lely; Cornelis Apparatus for milking animals
WO2001095741A1 (fr) * 2000-06-13 2001-12-20 Unilever N.V. Produit alimentaire contenant du lactobacille non-viable
EP1510135A1 (fr) * 2003-08-26 2005-03-02 Chr. Hansen A/S Aliment pour animaux de fermes comprenant enterococci probiotiques
WO2006041324A1 (fr) 2004-10-15 2006-04-20 Stanislaw Kalamarz Pate pour pain de seigle longue conservation et procedes de fabrication et de rafraichissement de ce pain
WO2007058614A1 (fr) * 2005-11-17 2007-05-24 Celac Sweden Ab Pain probiotique et son procede de fabrication
EP2578090A1 (fr) 2005-11-17 2013-04-10 Celac Sweden AB Nouvelles souches probiotiques
US8137952B2 (en) 2006-03-17 2012-03-20 Probac Ab Thermostable lactobacillus strains
WO2007108764A2 (fr) 2006-03-17 2007-09-27 Probac Ab Souches de lactobacillus thermostables
US10383342B2 (en) 2007-08-29 2019-08-20 Ganeden Biotech, Inc. Baked goods
WO2009069122A1 (fr) * 2007-11-26 2009-06-04 Zimand, Henri Procédé pour préparer un aliment probiotique pouvant être cuit
US9961910B2 (en) 2007-11-26 2018-05-08 DeGama Products, Ltd Process for preparing bakeable probiotic food
US8673377B2 (en) 2008-01-28 2014-03-18 Lallemand, Inc. Method for extending mold-free shelf life and improving flavor characteristics of baked goods
EP2249654A4 (fr) * 2008-01-28 2017-04-26 Lallemand, Inc. Procédé pour prolonger la durée de conservation sans pourriture et améliorer les caractéristiques aromatiques de produits de boulangerie et de pâtisserie
US9622502B2 (en) 2008-10-16 2017-04-18 Ganeden Biotech, Inc. Probiotic Bacillus pasta compositions
US10321704B2 (en) 2008-10-16 2019-06-18 Ganeden Biotech, Inc. Probiotic grain-based compositions
US11419355B2 (en) 2008-10-16 2022-08-23 Ganeden Biotech, Inc. Probiotic grain-based compositions
WO2011004375A1 (fr) 2009-07-09 2011-01-13 Rubin, Israel Compositions probiotiques résistant à la chaleur et aliments sains les comprenant
US11039637B2 (en) 2010-12-06 2021-06-22 Degama Berrier Ltd. Composition and method for improving stability and extending shelf life of probiotic bacteria and food products thereof
US10543175B1 (en) 2013-05-17 2020-01-28 Degama Berrier Ltd. Film composition and methods for producing the same

Also Published As

Publication number Publication date
AU4311993A (en) 1994-01-24
CA2138764A1 (fr) 1994-01-06
JPH08501209A (ja) 1996-02-13
DK83292D0 (da) 1992-06-24
EP0649281A1 (fr) 1995-04-26

Similar Documents

Publication Publication Date Title
US11653656B2 (en) Baked goods
CA1333888C (fr) Agent de fermentation
EP2578090B1 (fr) Nouvelles souches probiotiques
TW510782B (en) Foods and animal feeds including antimycotic agent
CN112400952B (zh) 一种果干天然酵母面团的制备方法及其应用
CN113388535B (zh) 一种主食发酵剂及其制备方法和应用
WO1994000019A1 (fr) Produit cuit contenant des micro-organismes viables et son procede de preparation
US3963835A (en) Fermented flour and method of preparation
WO2000010395A1 (fr) Levain
KR20080100067A (ko) 유산균 생균 함유 빵류 및 그 제조방법
US6524631B1 (en) Baking mixes which contain flour and have an enhanced shelf life and method and means for preparing same
WO2010119874A1 (fr) Souche de lactobacille et aliment ayant une activité antifongique
JPH04631B2 (fr)
Denkova et al. Freeze-dried sourdough starters
AU2015200006B2 (en) Baked Goods
KR20160062361A (ko) 유통기한이 연장된 찰보리빵 및 이의 제조방법
KR102463099B1 (ko) 전분 배양 고체 효모를 이용한 햄버거 번 제조방법
KR102463103B1 (ko) 전분 배양 고체 효모를 이용한 크라상 제조방법
KR102486964B1 (ko) 제빵 부산물을 포함하는 고체 배지 조성물 및 이를 이용한 건조 효모 제조방법
KR20180038425A (ko) 김치 유산균을 이용한 쌀 자연 발효종 제조방법을 이용한 제품
KR101842400B1 (ko) 김치 유산균을 이용한 쌀 자연 발효종의 제조방법
EP0191408A2 (fr) Méthodes et compositions pour améliorer la valeur nutritive d'aliments
Pronk et al. XYLANASE FROM THERMOMYCES LANUGINOSUS EXPRESSED IN FUSARIUM VENENATUM
KR20140029928A (ko) 발효두유 빙과 및 이의 제조방법

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BG BR CA CZ FI HU JP KP KR LK MG MN MW NO NZ PL RO RU SD SK UA US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2138764

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1993912692

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 1995 356343

Country of ref document: US

Date of ref document: 19950310

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 1993912692

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1993912692

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载